Browse by Journal Title
 | Up a level |
anticancer conjugates
Ferguson, Elaine L., Richardson, Simon C.W. and Duncan, Ruth (2010) Studies on the mechanism of action of dextrin−phospholipase A2 and its suitability for use in combination therapy. Molecular Pharmaceutics, 7 (2). pp. 510-521. ISSN 1543-8384 (Print), 1543-8392 (Online) (doi:10.1021/mp900232a)
cancer
Ferguson, Elaine L., Richardson, Simon C.W. and Duncan, Ruth (2010) Studies on the mechanism of action of dextrin−phospholipase A2 and its suitability for use in combination therapy. Molecular Pharmaceutics, 7 (2). pp. 510-521. ISSN 1543-8384 (Print), 1543-8392 (Online) (doi:10.1021/mp900232a)
dextrin
Ferguson, Elaine L., Richardson, Simon C.W. and Duncan, Ruth (2010) Studies on the mechanism of action of dextrin−phospholipase A2 and its suitability for use in combination therapy. Molecular Pharmaceutics, 7 (2). pp. 510-521. ISSN 1543-8384 (Print), 1543-8392 (Online) (doi:10.1021/mp900232a)
nanomedicines
Ferguson, Elaine L., Richardson, Simon C.W. and Duncan, Ruth (2010) Studies on the mechanism of action of dextrin−phospholipase A2 and its suitability for use in combination therapy. Molecular Pharmaceutics, 7 (2). pp. 510-521. ISSN 1543-8384 (Print), 1543-8392 (Online) (doi:10.1021/mp900232a)
PLA2
Ferguson, Elaine L., Richardson, Simon C.W. and Duncan, Ruth (2010) Studies on the mechanism of action of dextrin−phospholipase A2 and its suitability for use in combination therapy. Molecular Pharmaceutics, 7 (2). pp. 510-521. ISSN 1543-8384 (Print), 1543-8392 (Online) (doi:10.1021/mp900232a)
polymer therapeutics
Ferguson, Elaine L., Richardson, Simon C.W. and Duncan, Ruth (2010) Studies on the mechanism of action of dextrin−phospholipase A2 and its suitability for use in combination therapy. Molecular Pharmaceutics, 7 (2). pp. 510-521. ISSN 1543-8384 (Print), 1543-8392 (Online) (doi:10.1021/mp900232a)
PUMPT
Ferguson, Elaine L., Richardson, Simon C.W. and Duncan, Ruth (2010) Studies on the mechanism of action of dextrin−phospholipase A2 and its suitability for use in combination therapy. Molecular Pharmaceutics, 7 (2). pp. 510-521. ISSN 1543-8384 (Print), 1543-8392 (Online) (doi:10.1021/mp900232a)